Meta分析:两项全基因组关联研究确定3个酒精依赖新位点

2011-07-03 MedSci原创 MedSci原创

由于长期大量饮酒而产生的对酒的强烈渴望和嗜好,以至饮酒不能自制,一旦停止饮酒则产生精神和躯体的各种症状。酒精依赖的发生率由于社会文化背景不同而不同,男性明显多于女性,白种人多于黄种人。 病因和发病机理 ①生物学因素。遗传学研究发现,某些人具有对酒精依赖的先天遗传倾向;酒的代谢主要通过乙醇脱氢酶和乙醛脱氢酶的作用,乙醛脱氢酶活性较低的人少量饮酒即可感到身体不适,因此不会大量饮酒,也就难以产生酒

由于长期大量饮酒而产生的对酒的强烈渴望和嗜好,以至饮酒不能自制,一旦停止饮酒则产生精神和躯体的各种症状。酒精依赖的发生率由于社会文化背景不同而不同,男性明显多于女性,白种人多于黄种人。

病因和发病机理 ①生物学因素。遗传学研究发现,某些人具有对酒精依赖的先天遗传倾向;酒的代谢主要通过乙醇脱氢酶和乙醛脱氢酶的作用,乙醛脱氢酶活性较低的人少量饮酒即可感到身体不适,因此不会大量饮酒,也就难以产生酒精依赖。② 心理因素 。性情抑郁、羞怯、焦虑、紧张、不善交际的人,为了克服这些缺陷而饮酒,久而久之容易发生酒精依赖。③社会因素。如地区、种族、习俗、环境、职业以及公众和政府对酒的态度等,对酒精依赖的发生肯定是有影响的。从经常性饮酒发展到酒精依赖大约要经过10~20年。

最新刊登于期刊《Journal of Psychiatric Research》的一项研究确定3个酒精依赖的新位点。家庭、双胞胎和收养研究已明确证实,遗传因素在调节酒精依赖易感性中起重要作用。目前仅进行了数项有关酒精依赖的全基因组关联(GWA)研究;但是,很少有位点可被重复验证。本文对2项GWA研究进行了荟萃分析,这两项GWA研究纳入了1283名酒精依赖者和1416名对照白种人。通过meta分析,我们发现131个SNPs与酒精依赖相关 p <10-4。最佳的新信号是1q24 - q25 KIAA0040基因的rs6701037(p = 1.86 × 10-7),其次是位于2q22.1 THSD7B基因的rs1869324(P = 4.71 × 10-7)。第三个新位点是位于1p32.2的 NRD1(最具相关性SNP是 rs2842576 p = 7.90 × 10-6)。我们证实了11q24.4的PKNOX2与酒精依赖具有关联。Meta分析中PKNOX2最具关联的SNP(rs750338, p = 1.47 × 10-6)在澳大利亚双胞胎家庭研究的778个家庭中得到了重复验证(P = 1.39 × 10-2)。此外,家庭样本研究证实,meta分析中最强的侧翼区SNP与酒精依赖具有边缘相关(对于KIAA0040、NRD1和THSD7B,最强关联SNPs rs2269655、rs856613和rs10496768,p 值分别为 4.58 × 10-3,2.1 × 10-4和2.86 × 10-3)。此外,meta分析显示ALK、CASC4和SEMA5A与酒精依赖强相关(P <2 × 10-5)。

总之,我们确定了三个新位点(KIAA0040、THSD7B和NRD1),并确认以往研究报道的PKNOX2与酒精依赖相关联。这些发现为研究酒精依赖的发病机制提供了新见解。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=109664, encodeId=6b751096646b, content=学习下原文, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160705/IMG577BD33CADE985322.jpg, createdBy=4b231744214, createdName=xueshucao, createdTime=Fri Sep 02 13:03:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887308, encodeId=08fa188e30873, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Sat Nov 12 01:02:00 CST 2011, time=2011-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895610, encodeId=89cd1895610da, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Mar 28 07:02:00 CST 2012, time=2012-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018928, encodeId=6f362018928b9, content=<a href='/topic/show?id=ea545803682' target=_blank style='color:#2F92EE;'>#新位点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58036, encryptionId=ea545803682, topicName=新位点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Mon Jun 11 13:02:00 CST 2012, time=2012-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342205, encodeId=c023134220589, content=<a href='/topic/show?id=62eb2939954' target=_blank style='color:#2F92EE;'>#全基因组关联研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29399, encryptionId=62eb2939954, topicName=全基因组关联研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue Jul 05 00:02:00 CST 2011, time=2011-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546413, encodeId=9be715464138f, content=<a href='/topic/show?id=81eb2939373' target=_blank style='color:#2F92EE;'>#全基因组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29393, encryptionId=81eb2939373, topicName=全基因组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc2113925052, createdName=ms1692810954239974, createdTime=Tue Jul 05 00:02:00 CST 2011, time=2011-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575782, encodeId=72fa15e578247, content=<a href='/topic/show?id=5e1f954e563' target=_blank style='color:#2F92EE;'>#酒精依赖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95475, encryptionId=5e1f954e563, topicName=酒精依赖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5c116191457, createdName=xue8607, createdTime=Tue Jul 05 00:02:00 CST 2011, time=2011-07-05, status=1, ipAttribution=)]
    2016-09-02 xueshucao

    学习下原文

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=109664, encodeId=6b751096646b, content=学习下原文, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160705/IMG577BD33CADE985322.jpg, createdBy=4b231744214, createdName=xueshucao, createdTime=Fri Sep 02 13:03:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887308, encodeId=08fa188e30873, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Sat Nov 12 01:02:00 CST 2011, time=2011-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895610, encodeId=89cd1895610da, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Mar 28 07:02:00 CST 2012, time=2012-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018928, encodeId=6f362018928b9, content=<a href='/topic/show?id=ea545803682' target=_blank style='color:#2F92EE;'>#新位点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58036, encryptionId=ea545803682, topicName=新位点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Mon Jun 11 13:02:00 CST 2012, time=2012-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342205, encodeId=c023134220589, content=<a href='/topic/show?id=62eb2939954' target=_blank style='color:#2F92EE;'>#全基因组关联研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29399, encryptionId=62eb2939954, topicName=全基因组关联研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue Jul 05 00:02:00 CST 2011, time=2011-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546413, encodeId=9be715464138f, content=<a href='/topic/show?id=81eb2939373' target=_blank style='color:#2F92EE;'>#全基因组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29393, encryptionId=81eb2939373, topicName=全基因组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc2113925052, createdName=ms1692810954239974, createdTime=Tue Jul 05 00:02:00 CST 2011, time=2011-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575782, encodeId=72fa15e578247, content=<a href='/topic/show?id=5e1f954e563' target=_blank style='color:#2F92EE;'>#酒精依赖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95475, encryptionId=5e1f954e563, topicName=酒精依赖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5c116191457, createdName=xue8607, createdTime=Tue Jul 05 00:02:00 CST 2011, time=2011-07-05, status=1, ipAttribution=)]
    2011-11-12 guojianrong
  3. [GetPortalCommentsPageByObjectIdResponse(id=109664, encodeId=6b751096646b, content=学习下原文, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160705/IMG577BD33CADE985322.jpg, createdBy=4b231744214, createdName=xueshucao, createdTime=Fri Sep 02 13:03:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887308, encodeId=08fa188e30873, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Sat Nov 12 01:02:00 CST 2011, time=2011-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895610, encodeId=89cd1895610da, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Mar 28 07:02:00 CST 2012, time=2012-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018928, encodeId=6f362018928b9, content=<a href='/topic/show?id=ea545803682' target=_blank style='color:#2F92EE;'>#新位点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58036, encryptionId=ea545803682, topicName=新位点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Mon Jun 11 13:02:00 CST 2012, time=2012-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342205, encodeId=c023134220589, content=<a href='/topic/show?id=62eb2939954' target=_blank style='color:#2F92EE;'>#全基因组关联研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29399, encryptionId=62eb2939954, topicName=全基因组关联研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue Jul 05 00:02:00 CST 2011, time=2011-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546413, encodeId=9be715464138f, content=<a href='/topic/show?id=81eb2939373' target=_blank style='color:#2F92EE;'>#全基因组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29393, encryptionId=81eb2939373, topicName=全基因组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc2113925052, createdName=ms1692810954239974, createdTime=Tue Jul 05 00:02:00 CST 2011, time=2011-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575782, encodeId=72fa15e578247, content=<a href='/topic/show?id=5e1f954e563' target=_blank style='color:#2F92EE;'>#酒精依赖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95475, encryptionId=5e1f954e563, topicName=酒精依赖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5c116191457, createdName=xue8607, createdTime=Tue Jul 05 00:02:00 CST 2011, time=2011-07-05, status=1, ipAttribution=)]
    2012-03-28 一闲
  4. [GetPortalCommentsPageByObjectIdResponse(id=109664, encodeId=6b751096646b, content=学习下原文, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160705/IMG577BD33CADE985322.jpg, createdBy=4b231744214, createdName=xueshucao, createdTime=Fri Sep 02 13:03:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887308, encodeId=08fa188e30873, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Sat Nov 12 01:02:00 CST 2011, time=2011-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895610, encodeId=89cd1895610da, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Mar 28 07:02:00 CST 2012, time=2012-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018928, encodeId=6f362018928b9, content=<a href='/topic/show?id=ea545803682' target=_blank style='color:#2F92EE;'>#新位点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58036, encryptionId=ea545803682, topicName=新位点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Mon Jun 11 13:02:00 CST 2012, time=2012-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342205, encodeId=c023134220589, content=<a href='/topic/show?id=62eb2939954' target=_blank style='color:#2F92EE;'>#全基因组关联研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29399, encryptionId=62eb2939954, topicName=全基因组关联研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue Jul 05 00:02:00 CST 2011, time=2011-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546413, encodeId=9be715464138f, content=<a href='/topic/show?id=81eb2939373' target=_blank style='color:#2F92EE;'>#全基因组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29393, encryptionId=81eb2939373, topicName=全基因组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc2113925052, createdName=ms1692810954239974, createdTime=Tue Jul 05 00:02:00 CST 2011, time=2011-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575782, encodeId=72fa15e578247, content=<a href='/topic/show?id=5e1f954e563' target=_blank style='color:#2F92EE;'>#酒精依赖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95475, encryptionId=5e1f954e563, topicName=酒精依赖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5c116191457, createdName=xue8607, createdTime=Tue Jul 05 00:02:00 CST 2011, time=2011-07-05, status=1, ipAttribution=)]
    2012-06-11 ylz8403
  5. [GetPortalCommentsPageByObjectIdResponse(id=109664, encodeId=6b751096646b, content=学习下原文, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160705/IMG577BD33CADE985322.jpg, createdBy=4b231744214, createdName=xueshucao, createdTime=Fri Sep 02 13:03:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887308, encodeId=08fa188e30873, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Sat Nov 12 01:02:00 CST 2011, time=2011-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895610, encodeId=89cd1895610da, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Mar 28 07:02:00 CST 2012, time=2012-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018928, encodeId=6f362018928b9, content=<a href='/topic/show?id=ea545803682' target=_blank style='color:#2F92EE;'>#新位点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58036, encryptionId=ea545803682, topicName=新位点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Mon Jun 11 13:02:00 CST 2012, time=2012-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342205, encodeId=c023134220589, content=<a href='/topic/show?id=62eb2939954' target=_blank style='color:#2F92EE;'>#全基因组关联研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29399, encryptionId=62eb2939954, topicName=全基因组关联研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue Jul 05 00:02:00 CST 2011, time=2011-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546413, encodeId=9be715464138f, content=<a href='/topic/show?id=81eb2939373' target=_blank style='color:#2F92EE;'>#全基因组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29393, encryptionId=81eb2939373, topicName=全基因组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc2113925052, createdName=ms1692810954239974, createdTime=Tue Jul 05 00:02:00 CST 2011, time=2011-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575782, encodeId=72fa15e578247, content=<a href='/topic/show?id=5e1f954e563' target=_blank style='color:#2F92EE;'>#酒精依赖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95475, encryptionId=5e1f954e563, topicName=酒精依赖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5c116191457, createdName=xue8607, createdTime=Tue Jul 05 00:02:00 CST 2011, time=2011-07-05, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=109664, encodeId=6b751096646b, content=学习下原文, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160705/IMG577BD33CADE985322.jpg, createdBy=4b231744214, createdName=xueshucao, createdTime=Fri Sep 02 13:03:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887308, encodeId=08fa188e30873, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Sat Nov 12 01:02:00 CST 2011, time=2011-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895610, encodeId=89cd1895610da, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Mar 28 07:02:00 CST 2012, time=2012-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018928, encodeId=6f362018928b9, content=<a href='/topic/show?id=ea545803682' target=_blank style='color:#2F92EE;'>#新位点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58036, encryptionId=ea545803682, topicName=新位点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Mon Jun 11 13:02:00 CST 2012, time=2012-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342205, encodeId=c023134220589, content=<a href='/topic/show?id=62eb2939954' target=_blank style='color:#2F92EE;'>#全基因组关联研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29399, encryptionId=62eb2939954, topicName=全基因组关联研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue Jul 05 00:02:00 CST 2011, time=2011-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546413, encodeId=9be715464138f, content=<a href='/topic/show?id=81eb2939373' target=_blank style='color:#2F92EE;'>#全基因组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29393, encryptionId=81eb2939373, topicName=全基因组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc2113925052, createdName=ms1692810954239974, createdTime=Tue Jul 05 00:02:00 CST 2011, time=2011-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575782, encodeId=72fa15e578247, content=<a href='/topic/show?id=5e1f954e563' target=_blank style='color:#2F92EE;'>#酒精依赖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95475, encryptionId=5e1f954e563, topicName=酒精依赖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5c116191457, createdName=xue8607, createdTime=Tue Jul 05 00:02:00 CST 2011, time=2011-07-05, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=109664, encodeId=6b751096646b, content=学习下原文, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160705/IMG577BD33CADE985322.jpg, createdBy=4b231744214, createdName=xueshucao, createdTime=Fri Sep 02 13:03:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887308, encodeId=08fa188e30873, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Sat Nov 12 01:02:00 CST 2011, time=2011-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1895610, encodeId=89cd1895610da, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Mar 28 07:02:00 CST 2012, time=2012-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018928, encodeId=6f362018928b9, content=<a href='/topic/show?id=ea545803682' target=_blank style='color:#2F92EE;'>#新位点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58036, encryptionId=ea545803682, topicName=新位点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3fce464, createdName=ylz8403, createdTime=Mon Jun 11 13:02:00 CST 2012, time=2012-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342205, encodeId=c023134220589, content=<a href='/topic/show?id=62eb2939954' target=_blank style='color:#2F92EE;'>#全基因组关联研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29399, encryptionId=62eb2939954, topicName=全基因组关联研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Tue Jul 05 00:02:00 CST 2011, time=2011-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546413, encodeId=9be715464138f, content=<a href='/topic/show?id=81eb2939373' target=_blank style='color:#2F92EE;'>#全基因组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29393, encryptionId=81eb2939373, topicName=全基因组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc2113925052, createdName=ms1692810954239974, createdTime=Tue Jul 05 00:02:00 CST 2011, time=2011-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575782, encodeId=72fa15e578247, content=<a href='/topic/show?id=5e1f954e563' target=_blank style='color:#2F92EE;'>#酒精依赖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95475, encryptionId=5e1f954e563, topicName=酒精依赖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5c116191457, createdName=xue8607, createdTime=Tue Jul 05 00:02:00 CST 2011, time=2011-07-05, status=1, ipAttribution=)]